Neohesperidin inhibits cardiac remodeling induced by Ang II in vivo and in vitro.

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Jingsi ZhangYanchun Ding

Abstract

Cardiac hypertrophy and remodeling are among the major health challenges facing countries around the world today. Neohesperidin plays an important role in influencing cell apoptosis, cell growth, tumorigenesis and tumor microenvironment, but the mechanism and role of Neohesperidin in cardiac hypertrophy and remodeling caused by Angiotensin II has not been fully elucidated. This study used Angiotensin II to induce cardiac hypertrophy and cardiac remodeling in mice. Echocardiography was used to evaluate cardiac function, H&E and Masson trichrome staining were used to detect myocardial histological changes. Cardiac cell size was determined by WGA staining. The protein content of the signaling pathway was detected by Western blot, and the mRNA expression of fibrosis and hypertrophy markers was detected by qPCR. DHE staining was used to detect oxidative stress. We also observed the effect of Neohesperidin on Ang II-induced NRCMs. The results showed that neohesperidin can significantly inhibit Ang II-induced myocardial contractile dysfunction, cardiac hypertrophy, myocardial fibrosis, myocardial oxidative stress and inflammation. These results suggest that Neohesperidin can alleviate cardiac hypertrophy and remodeling caused by Ang I...Continue Reading

References

Jul 3, 2008·Journal of Agricultural and Food Chemistry·O Benavente-García, J Castillo
Mar 13, 2009·The New England Journal of Medicine·Angeliki AsimakiJeffrey E Saffitz
Aug 25, 2010·Circulation·Karl ToischerGerd Hasenfuss
Sep 8, 2010·The New England Journal of Medicine·Carolyn Y HoChristine E Seidman
Jun 21, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Jiqiu ChenRoger J Hajjar
Dec 6, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Latronya T McCollumE Ann Tallant
Oct 4, 2014·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Jing-Si ZhangYing Liu
Jun 7, 2018·Physiological Reviews·Steven J ForresterSatoru Eguchi
Dec 7, 2018·Molecular Nutrition & Food Research·Xiao YanHui-Hua Li
May 6, 2019·Journal of Molecular and Cellular Cardiology·Nazari PolidovitchPeter H Backx
May 8, 2019·Circulation. Cardiovascular Imaging·Gernot PichlerAna Navas-Acien
May 9, 2019·Nature Reviews. Cardiology·Charlotte AnderssonRamachandran S Vasan
May 10, 2019·Heart Failure Reviews·Yanqing GuoJian An
May 11, 2019·International Journal of Molecular Sciences·Thomas J LaRoccaSima T Tarzami
Feb 27, 2020·Circulation Research·Shiju YeGuang Liang

❮ Previous
Next ❯

Citations

Feb 22, 2021·Carbohydrate Research·Penghua ShuWenhan Yi
May 10, 2021·International Journal of Biological Macromolecules·Naymul KarimWei Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.